These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1389 related items for PubMed ID: 12720118

  • 1. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA.
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [Abstract] [Full Text] [Related]

  • 2. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V.
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [Abstract] [Full Text] [Related]

  • 3. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D, Treon SP, Emmanouilides C, Branagan AR, Byrd JC, Bladé J, Kimby E.
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [Abstract] [Full Text] [Related]

  • 4. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG.
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [Abstract] [Full Text] [Related]

  • 5. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, Pestronk A, Rajkumar V, Treon SP.
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [Abstract] [Full Text] [Related]

  • 6. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U, Ferreri AJ, Montoto S.
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [Abstract] [Full Text] [Related]

  • 7. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Gobbi PG, Baldini L, Broglia C, Goldaniga M, Comelli M, Morel P, Morra E, Cortelazzo S, Bettini R, Merlini G.
    Clin Cancer Res; 2005 Mar 01; 11(5):1786-90. PubMed ID: 15756000
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA, Kyrtsonis MC, Kontopidou FN, Vassilakopoulos TP, Siakantaris MP, Dimopoulou MN, Kittas C, Angelopoulou MK.
    Semin Oncol; 2003 Apr 01; 30(2):201-5. PubMed ID: 12720136
    [Abstract] [Full Text] [Related]

  • 9. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
    Greco A, Tedeschi A, Varettoni M, Nichelatti M, Paris L, Ricci F, Vismara E, Morra E.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 01; 11(1):77-9. PubMed ID: 21454196
    [Abstract] [Full Text] [Related]

  • 10. Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.
    Ocio EM, del Carpio D, Caballero Á, Alonso J, Paiva B, Pesoa R, Villaescusa T, López-Anglada L, Vidriales B, García-Sanz R.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 01; 11(1):93-5. PubMed ID: 21454201
    [Abstract] [Full Text] [Related]

  • 11. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D, Pathak D, Shyambabu C, Koner BC, Swaminathan RP.
    Indian J Pathol Microbiol; 2004 Oct 01; 47(4):515-7. PubMed ID: 16295380
    [Abstract] [Full Text] [Related]

  • 12. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P.
    J Clin Oncol; 2005 Jul 20; 23(21):4662-8. PubMed ID: 16034042
    [Abstract] [Full Text] [Related]

  • 13. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 20; 11(1):74-6. PubMed ID: 21454195
    [Abstract] [Full Text] [Related]

  • 14. Prognosis and treatment of Waldenström's macroglobulinemia.
    Louw VJ, Webb MJ.
    Transfus Apher Sci; 2010 Apr 20; 42(2):193-7. PubMed ID: 20117052
    [Abstract] [Full Text] [Related]

  • 15. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
    San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sánchez-Guijo F, Sánchez ML, Escribano L, Bárez A, Moro MJ, Hernández J, Aguilera C, Cuello R, García-Frade J, López R, Portero J, Orfao A.
    Semin Oncol; 2003 Apr 20; 30(2):187-95. PubMed ID: 12720134
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations.
    Treon SP, Kelliher A, Keele B, Frankel S, Emmanouilides C, Kimby E, Schlossman R, Mitsiades N, Mitsiades C, Preffer F, Anderson KC.
    Semin Oncol; 2003 Apr 20; 30(2):248-52. PubMed ID: 12720146
    [Abstract] [Full Text] [Related]

  • 19. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
    Remstein ED, Hanson CA, Kyle RA, Hodnefield JM, Kurtin PJ.
    Semin Oncol; 2003 Apr 20; 30(2):182-6. PubMed ID: 12720133
    [Abstract] [Full Text] [Related]

  • 20. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
    Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, Siakantaris MP, Kittas C.
    Semin Hematol; 1999 Apr 20; 36(2):104-14. PubMed ID: 10319379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.